2-[2-(3,3-dimethyloxiranyl)vinyl]-2,3-dimethyloxirane
|
- $29.8 - $502.14
- Product name: 2-[2-(3,3-dimethyloxiranyl)vinyl]-2,3-dimethyloxirane
- CAS: 3765-28-4
- MF: C10H16O2
- MW: 168.23
- EINECS:223-185-1
- MDL Number:MFCD00086225
- Synonyms:2-[2-(3,3-dimethyloxiranyl)vinyl]-2,3-dimethyloxirane ;ALLOOCIMENEDIEPOXIDE;2,6-Dimethyl-2,3:6,7-diepoxy-4-octene;Ai3-27678;Einecs 223-185-1;Oxirane, 2-(2-(3,3-dimethyloxiranyl)ethenyl)-2,3-dimethyl-;ALLOOCIMENE DIOXIDE (MIXTURE OF CIS AND TRANS);Oxirane, 2-[2-(3,3-dimethyloxiranyl)ethenyl]-2,3-dimethyl- (9CI)
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Sigma-Aldrich
Package
- 5MG
- 1g
- 1 unit
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0309189
- Product descriptionALLOOCIMENE DIOXIDE 95.00%
- Packaging5MG
- Price$502.14
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberS418633
- Product descriptionALLOOCIMENE DIOXIDE (MIXTURE OF CIS AND TRANS) AldrichCPR
- Packaging1g
- Price$29.8
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberS418633
- Product descriptionALLOOCIMENE DIOXIDE (MIXTURE OF CIS AND TRANS) AldrichCPR
- Packaging1 unit
- Price$32.7
- Updated2026-04-30
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | CHM0309189 | ALLOOCIMENE DIOXIDE 95.00% | 5MG | $502.14 | 2021-12-16 | Buy |
| Sigma-Aldrich | S418633 | ALLOOCIMENE DIOXIDE (MIXTURE OF CIS AND TRANS) AldrichCPR | 1g | $29.8 | 2024-03-01 | Buy |
| Sigma-Aldrich | S418633 | ALLOOCIMENE DIOXIDE (MIXTURE OF CIS AND TRANS) AldrichCPR | 1 unit | $32.7 | 2026-04-30 | Buy |
Properties
Safety Information
| Symbol(GHS): |
![]()
|
||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Danger | ||||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
||||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|





